Les candidoses vulvovaginales : facteurs de risque et particularités cliniques et mycologiques
Authors:
- S. AnaneSAS. Anane
- E. KaouechEKE. Kaouech
- B. ZouariBZB. Zouari
- S. BelhadjSBS. Belhadj
- K. KallelKKK. Kallel
- E. ChakerECE. Chaker
- 1 March 2010
- journal article
- Published by Elsevier in Journal of Medical Mycology
- Vol. 20 (1) , 36-41
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Can intrauterine contraceptive devices be a Candida albicans reservoir?Contraception, 2008
- Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factorsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- Vaginitis in Turkish women: symptoms, epidemiologic – microbiologic associationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Prévalence et aspects cliniques des mycoses superficielles chez le diabétique tunisien en milieu hospitalierMedecine Et Maladies Infectieuses, 2004
- Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in womenAmerican Journal of Obstetrics and Gynecology, 2002
- Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetesBMC Infectious Diseases, 2002
- Intrauterine device use and some issues related to sexually transmitted disease screening and occurrenceContraception, 2000
- Relationship of Fungal Vaginitis Therapy to Prior Antibiotic ExposureInfectious Diseases in Obstetrics and Gynecology, 2000
- Treatment of Vulvovaginal Candidiasis in Patients With DiabetesDiabetes Care, 1998
- The epidemiology of vulvovaginal candidiasis: risk factors.American Journal of Public Health, 1990